In the News

51 News Items found
Patient Jason Weiner and his family
A phase 3 trial for myelofibrosis found that adding pelabresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.
MSK radiation oncologist and head and neck specialist Dr. Nadeem Riaz.
Article
Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.
Man with glasses holding a dental prosthetic and tools in his hands.
Feature
A vital part of MSK's mission is to get patients back to feeling like themselves.
healthy foods
6 Tips to Improve Your Immunity
Learn how to keep your immune system balanced.
Nitya Raj
Learn the keys to a successful telemedicine visit from a cancer specialist at Memorial Sloan Kettering.
Group of racially diverse boys and girls lying on grass and conversing.
Support
Vaccinating children against the human papillomavirus can protect them from developing many types of cancer. Here’s what you need to know.
Lisa Toth donates plasma with help from Anli Chang
In the Clinic
Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.
Doctor rubbing down patient's arm with alcohol swab
Ask the Expert
Five Myths About the Flu Shot
MSK infectious disease specialist Monika Shah debunks common myths about the flu shot.
Medical illustration of nanoparticle spheres attacking cancer cell, which is beginning to disintegrate.
In the Lab
Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.
Memorial Sloan Kettering physician-scientist Michel Sadelain.
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.